☰

Benjamin Titz, Ph.D. - Publications

Affiliations: 
2012 Medical Physics University of Wisconsin, Madison, Madison, WI 
Area:
Oncology, Radiology
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hall LT, Titz B, Baidya N, van der Kolk AG, Robins HI, Otto M, Perlman SB, Weichert JP, Kuo JS. [I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 31183841 DOI: 10.1007/S11307-019-01362-1  0.495
2018 Grudzinski J, Marsh I, Titz B, Jeffery J, Longino M, Kozak K, Lange K, Larrabee J, Weichmann A, Moser A, Bednarz B. CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer. Cancer Biotherapy & Radiopharmaceuticals. 33: 87-95. PMID 29641256 DOI: 10.1089/Cbr.2017.2376  0.608
2017 Hall LT, Titz B, Robins HI, Bednarz BP, Perlman SB, Weichert JP, Kuo JS. PET/CT imaging of the diapeutic alkylphosphocholine analog (124)I-CLR1404 in high and low-grade brain tumors. American Journal of Nuclear Medicine and Molecular Imaging. 7: 157-166. PMID 28913154  0.436
2017 Besemer AE, Titz B, Grudzinski JJ, Weichert JP, Kuo JS, Robins HI, Hall LT, Bednarz BP. Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404. Physics in Medicine and Biology. 62: 6008-6025. PMID 28682793 DOI: 10.1088/1361-6560/Aa716D  0.75
2015 Marino R, Baiu DC, Bhattacharya S, Titz B, Hebron E, Menapace BD, Singhal S, Eickhoff JC, Asimakopoulos F, Weichert JP, Otto M. Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma. American Journal of Cancer Research. 5: 3422-35. PMID 26807322  0.424
2015 Pak C, Callander NS, Young EW, Titz B, Kim K, Saha S, Chng K, Asimakopoulos F, Beebe DJ, Miyamoto S. MicroC(3): an ex vivo microfluidic cis-coculture assay to test chemosensitivity and resistance of patient multiple myeloma cells. Integrative Biology : Quantitative Biosciences From Nano to Macro. 7: 643-54. PMID 25998180 DOI: 10.1039/C5Ib00071H  0.433
2015 Besemer A, Grudzinski J, Titz B, Bednarz JB. WE-EF-BRA-04: Evaluation of Dosimetric Uncertainties in Individualized Targeted Radionuclide Therapy (TRT) Treatment Planning Using Pre-Clinical Data Medical Physics. 42: 3675-3675. DOI: 10.1118/1.4925983  0.703
2014 Besemer A, Titz B, Grudzinski J, Weichert J, Hall L, Bednarz B. SU-E-T-256: Optimizing the Combination of Targeted Radionuclide Therapy Agents Using a Multi-Scale Patient-Specific Monte Carlo Dosimetry Platform. Medical Physics. 41: 282. PMID 28037043 DOI: 10.1118/1.4888587  0.669
2014 Grudzinski JJ, Titz B, Kozak K, Clarke W, Allen E, Trembath L, Stabin M, Marshall J, Cho SY, Wong TZ, Mortimer J, Weichert JP. A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety. Plos One. 9: e111652. PMID 25402488 DOI: 10.1371/Journal.Pone.0111652  0.68
2014 Weichert JP, Clark PA, Kandela IK, Vaccaro AM, Clarke W, Longino MA, Pinchuk AN, Farhoud M, Swanson KI, Floberg JM, Grudzinski J, Titz B, Traynor AM, Chen HE, Hall LT, et al. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy. Science Translational Medicine. 6: 240ra75. PMID 24920661 DOI: 10.1126/Scitranslmed.3007646  0.736
2014 Pak C, Callander NS, Young EW, Titz B, Kim K, Chng K, Miyamoto S, Beebe DJ. Initial Results of an Ex Vivo Microfluidic Cis-Coculture Csra to Predict Response for Myeloma Patients Blood. 124: 4706-4706. DOI: 10.1182/Blood.V124.21.4706.4706  0.487
2014 Valentinuzzi D, Simoncic U, Titz B, Jeraj R. MO-G-BRF-05: Determining Response to Anti-Angiogenic Therapies with Monte Carlo Tumor Modeling Medical Physics. 41: 435-435. DOI: 10.1118/1.4889197  0.686
2013 Titz B, Grudzinski JJ, Barbee DL, Weichert JP. TU-E-141-08: Dosimetric Impact of Partial Volume Correction On PET-Based Targeted Radionuclide Therapy Planning. Medical Physics. 40: 448. PMID 28518796 DOI: 10.1118/1.4815436  0.679
2013 Besemer A, Grudzinski J, Titz B, Wickre P, Hall L, Weichert J, Bednarz B. SU-F-500-01: Towards Personalized Dosimetry Using Diapeutic Radiopharmaceuticals. Medical Physics. 40: 382. PMID 28518396 DOI: 10.1118/1.4815191  0.712
2012 Titz B, Kozak KR, Jeraj R. Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data. Physics in Medicine and Biology. 57: 6079-101. PMID 22972469 DOI: 10.1088/0031-9155/57/19/6079  0.646
2012 Harmon S, Titz B, Jeraj R. TH-C-213AB-10: Computational Tumor Modeling for Dose Painting Candidate Stratification Medical Physics. 39: 3995-3995. DOI: 10.1118/1.4736299  0.631
2011 Adhikarla V, Titz B, Jeraj R. TH-C-220-08: Simulating the Effects of Molecular Targeted Drugs on Tumor and Vasculature Development Using An Imaging-Based, Computational Model Medical Physics. 38: 3864-3864. DOI: 10.1118/1.3613551  0.783
2011 Titz B, Jallow N, Jeraj R. TH-C-220-03: Extraction of Radiosensitivity Coefficients from Multiparametric Molecular Imaging Data through Computational Tumor Modeling Medical Physics. 38: 3862-3863. DOI: 10.1118/1.3613546  0.789
2010 Titz B, Vanderhoek M, Simoncic U, Adhikarla V, Jeraj R. MO-E-BRB-05: A Computational Tumor Modeling Framework for the Optimization of Molecular Targeted Therapies Medical Physics. 37: 3356-3356. DOI: 10.1118/1.3469115  0.769
2010 Adhikarla V, Simoncic U, Titz B, Jeraj R. MO-E-BRB-01: Development of a Computational Model for Quantifying Vascular Response to TKI Therapy Medical Physics. 37: 3355-3355. DOI: 10.1118/1.3469111  0.774
2009 Scully P, Simoncic U, Titz B, Jeraj R. WE-D-303A-06: FLT PET Imaging of Bone Marrow Toxicity: An in Vivo Biodosimeter Medical Physics. 36: 2776-2776. DOI: 10.1118/1.3182533  0.579
2009 Adhikarla V, Titz B, Kozak K, Jeraj R. TU-C-BRB-07: Incorporation of Angiogenesis Into a Stochastic Imaging-Based Tumor Vasculature Model Medical Physics. 36: 2723-2723. DOI: 10.1118/1.3182332  0.775
2009 Titz B, Adhikarla V, Kozak K, Jeraj R. SU-FF-T-489: Simulating the Effects of Anti-Angiogenic Therapy Using Voxel-Based Biological Parameters Derived From Functional Imaging Medical Physics. 36: 2635-2635. DOI: 10.1118/1.3181987  0.782
2008 Titz B, Jeraj R. An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response. Physics in Medicine and Biology. 53: 4471-88. PMID 18677042 DOI: 10.1088/0031-9155/53/17/001  0.612
2008 Nyflot M, Grudzinski J, Titz B, Armstrong E, Wheeler D, Harari P, Jeraj R. TH-C-351-04: 18F-FLT PET Imaging of Proliferative Response to An EGFR Inhibitor in HNSCC Xenograft Mouse Models Medical Physics. 35: 2975-2975. DOI: 10.1118/1.2962860  0.784
2008 Titz B, Jeraj R. TU-D-352-06: Modeling the Effect of Different Oxygenation Levels On Radiation Therapy Response Using Kinetic Parameters Derived From PET/CT Imaging Medical Physics. 35: 2899-2899. DOI: 10.1118/1.2962564  0.7
2007 Titz B, Jorabchi K, Suresh K, Jeraj R. SU-FF-T-32: A Novel Continuum Mechanics Approach Towards Multiscale, Stochastic Tumor Modeling Based On Multimodality Imaging Medical Physics. 34: 2408-2408. DOI: 10.1118/1.2760677  0.655
2006 Jeraj R, Rodriguez M, Titz B, Mathias J, Huttenlocher A. TH-E-230A-04: Total and Partial-Body Zebrafish Irradiation Medical Physics. 33: 2295-2295. DOI: 10.1118/1.2241966  0.498
2006 Titz B, Jeraj R. SU-FF-T-27: A Monte Carlo Based Tumor Model Medical Physics. 33: 2056-2056. DOI: 10.1118/1.2240930  0.641
Show low-probability matches.